Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants in ATM , BRCA1 , BRCA2 , CHEK2 , and PALB2 .
Siddhartha YadavNicholas J BoddickerJie NaEric C PolleyChunling HuSteven N HartRohan D GnanaolivuNicole L LarsonSusan HoltegaardHuaizhi HuangCarolyn A DunnLauren R TerasAlpa V PatelJames V LaceySusan L NeuhausenMaría Elena MartínezChristopher A HaimanFei ChenKathryn J RuddyJanet E OlsonIsabelle DurotAllison W KurianDale R SandlerKatie M O'BrienJack A TaylorClarice R WeinbergHoda Anton-CulverArgyrios ZiogasGary ZirpoliDavid E GoldgarJulie R PalmerSusan M DomchekJeffrey N WeitzelKatherine L NathansonPeter KraftFergus J CouchPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
are at substantially increased risk of CBC and may benefit from enhanced surveillance and risk reduction strategies.